Navigation Links
Video: Schering-Plough Introduces TINACTIN(R) CHILL, a Line of Antifungal Products Geared Specifically to Young Males
Date:5/19/2009

Specially designed microsite (www.meettheburns.com) targets first time athlete's foot sufferers and parents.

KENILWORTH, N.J., May 19 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced the arrival of TINACTIN(R) CHILL, an antifungal spray for the treatment of athlete's foot. TINACTIN CHILL is available in two formulations, liquid spray and deodorant powder spray.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090519/NY19030 )

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/tinactin/38431/

Athlete's foot is an infection caused by direct contact with fungus. People are most susceptible when their feet are sweating or when wearing shoes that lack proper ventilation. The condition is commonly picked up by walking barefoot in locker rooms, pools and other public areas.

TINACTIN CHILL is targeted to address the needs of the first time athlete's foot sufferer, which are primarily young males ages 14 to 22. "Research shows that experiencing athlete's foot for the first time can be very frightening and intimidating for young men," said John O'Mullane, PhD., group vice president, research and development, Schering-Plough Consumer Healthcare. "Our research indicated that to reach this age group we would need to go beyond the traditional methods of communication with our customers."

To reach this audience, Schering-Plough developed an innovative Web site, www.meettheburns.com. The site features a series of "Webisodes" highlighting the fictitious Burns family and a character named "Gus" representing fungus. Each segment presents an athlete's foot treatment message in a situation comedy style that is entertaining and identifies well with teens. "Many young men are reluctant to talk about their situation when they first experience athlete's foot," O'Mullane said. "However, they often seek information on the Internet. By developing this Web site, we can reach young men and help inform them and their parents that there are effective and easy to use treatments for this common condition."

About TINACTIN CHILL

TINACTIN CHILL is clinically proven to cure most athlete's foot and can even help prevent athlete's foot with daily use. The Liquid Spray contains ingredients that provide an extra cooling sensation and the Deodorant Powder Spray will fight odor all day long in addition to treating athlete's foot.

TINACTIN CHILL is available at most mass retailers, drugstores, grocery stores and online outlets.

About Schering-Plough

Schering-Plough Consumer Health Care is the U.S. over-the-counter (OTC) and consumer products business unit of Schering-Plough, an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Video: Nutrition Comes to NASCAR
2. Video: Circulatory Care of New Jersey
3. Video: GEN Video Hits Home with Web Audience
4. Video: Beyond the Red Door: Gildas Club Worldwide and DKNY Host Successful Benefit Event
5. Video: Food Expert B. Smith to Provide Healthy Menu Makeovers
6. Video: New FDA-Approved Sun Protectant Saves Skin All Year Round
7. Video: Kyphon Supports World Osteoporosis Day on October 20, 2007 to Raise Awareness of Osteoporosis and Spinal Fracture Risk
8. Video: Trinity Mother Frances Neurosurgeon First in Region to Remove Brain Tumor Using Unique Surgical Procedure
9. Video: Holiday Safety Is Important
10. Video: Grin Big With an Award-Winning Smile
11. Video: BSP Pharma Inc. Announces Groundbreaking Findings from The Australian Centre for Complementary Medicine Education and Research Joint Health Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2017)... (PRWEB) , ... April 29, 2017 , ... ... celebrate the profession and recognize the positive impact veterinarians have on animal health ... and the World Organization for Animal Health (OIE) choose a theme each year ...
(Date:4/28/2017)... NC (PRWEB) , ... April 28, 2017 , ... ... announce its new partnership with the Home Care Association of America (HCAOA). This ... and Private Duty Accreditation services, as well as discounts on Accreditation University (AU) ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Beginning in ... of their formulas. This begins with the popular ClearLungs Extra Strength formula. To ensure ... changing the formula in the following ways:, , Removal of ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... distribution of the GlycoMark test throughout the Northeast U.S. , GlycoMark is ... with diabetes. The GlycoMark test provides a clinically proven one- to two-week measure ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... MINNEAPOLIS , April 20, 2017  Cogentix ... company focused on providing the Urology, Uro/Gyn and ... reported that Ash Keswani has joined the Company ... In this newly created position, Mr. Keswani will ... and CEO. "Our organization is delighted ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Market and Increasing Usage of Complex Biologics during the Forecast Period" ... ... 20 Billion in 2015 to around USD 26 Billion by 2020. ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ...
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
Breaking Medicine Technology: